Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Aug;74(8):1105–1108. doi: 10.1136/jnnp.74.8.1105

Evidence of underdiagnosis of myasthenia gravis in older people

A Vincent 1, L Clover 1, C Buckley 1, J Evans 1, P Rothwell 1
PMCID: PMC1738592  PMID: 12876244

Abstract

Background: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoantibodies directed at the acetylcholine receptor (AChR) on the postsynaptic membrane of the neuromuscular junction. There is anecdotal evidence that the diagnosis is sometimes missed in older patients.

Objective: To examine the incidence and age distribution of positive AChR antibodies in samples referred to diagnostic laboratories in the UK, and the prevalence of positive AChR antibodies in samples from a cohort of older individuals.

Methods: Positive AChR antibody tests were identified from all UK centres registered for the assay with the European quality assurance scheme (EQAS) during 1997–99, and the age and sex specific incidence was calculated, based on the UK population. The prevalence of AChR antibodies in sera from a sample of 2000 individuals aged ≥ 60 years was determined.

Results: 3183 individuals had positive AChR antibody tests on routine screening during the years 1997 to 1999 in the UK, giving an annual incidence of 1.8/100 000. In both sexes, the age specific incidence rose steeply between the ages of 45 and 74, reaching 9.9/100 000 in men, and then fell, with a sharp decline above the age of 80. In the prevalence study, whereas only one serum from individuals aged 60–74 years was positive for AChR antibodies (0.12%), sera from eight individuals aged ≥ 75 years were positive (0.7%). Only one had a previous clinical diagnosis of myasthenia gravis but four others had histories of stroke or transient ischaemic attacks.

Conclusions: The sharp fall in the incidence of clinically recognised myasthenia gravis in people over 80 years of age in our national AChR antibody incidence study, and the high prevalence of previously unrecognised positive AChR antibodies in those ≥ 75 years old, suggest that myasthenia gravis may be substantially underdiagnosed in older people.

Full Text

The Full Text of this article is available as a PDF (151.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarli J. A. Late-onset myasthenia gravis: a changing scene. Arch Neurol. 1999 Jan;56(1):25–27. doi: 10.1001/archneur.56.1.25. [DOI] [PubMed] [Google Scholar]
  2. Antonini G., Morino S., Gragnani F., Fiorelli M. Myasthenia gravis in the elderly: a hospital based study. Acta Neurol Scand. 1996 Apr;93(4):260–262. doi: 10.1111/j.1600-0404.1996.tb00517.x. [DOI] [PubMed] [Google Scholar]
  3. Bowling A. Ageism in cardiology. BMJ. 1999 Nov 20;319(7221):1353–1355. doi: 10.1136/bmj.319.7221.1353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Psychol Med. 1998 Mar;28(2):319–335. doi: 10.1017/s0033291797006272. [DOI] [PubMed] [Google Scholar]
  5. Compston D. A., Vincent A., Newsom-Davis J., Batchelor J. R. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain. 1980 Sep;103(3):579–601. doi: 10.1093/brain/103.3.579. [DOI] [PubMed] [Google Scholar]
  6. Graef L. M., Lutsep H. L., Norbash A., Albers G. W. Use of fluid attenuating inversion recovery, MR angiogram, and diffusion-weighted MRI techniques for assessment of pontine infarction in a patient treated with radiation therapy for pituitary neoplasm. Neurology. 1997 Feb;48(2):540–542. doi: 10.1212/wnl.48.2.540. [DOI] [PubMed] [Google Scholar]
  7. Grant P. T., Henry J. M., McNaughton G. W. The management of elderly blunt trauma victims in Scotland: evidence of ageism? Injury. 2000 Sep;31(7):519–528. doi: 10.1016/s0020-1383(00)00038-3. [DOI] [PubMed] [Google Scholar]
  8. Kahana E., Alter M., Feldman S. Amyotrophic lateral sclerosis: a population study. J Neurol. 1976 Jun 14;212(3):205–213. doi: 10.1007/BF00314523. [DOI] [PubMed] [Google Scholar]
  9. Kearney N., Miller M. Elderly patients with cancer: an ethical dilemma. Crit Rev Oncol Hematol. 2000 Feb;33(2):149–154. doi: 10.1016/s1040-8428(99)00065-7. [DOI] [PubMed] [Google Scholar]
  10. Kleiner-Fisman G., Kott H. S. Myasthenia gravis mimicking stroke in elderly patients. Mayo Clin Proc. 1998 Nov;73(11):1077–1078. doi: 10.4065/73.11.1077. [DOI] [PubMed] [Google Scholar]
  11. Kluin K. J., Bromberg M. B., Feldman E. L., Simmons Z. Dysphagia in elderly men with myasthenia gravis. J Neurol Sci. 1996 Jun;138(1-2):49–52. doi: 10.1016/0022-510x(95)00329-z. [DOI] [PubMed] [Google Scholar]
  12. Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov;26(11):1054–1059. doi: 10.1212/wnl.26.11.1054. [DOI] [PubMed] [Google Scholar]
  13. Poulas K., Tsibri E., Kokla A., Papanastasiou D., Tsouloufis T., Marinou M., Tsantili P., Papapetropoulos T., Tzartos S. J. Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):352–356. doi: 10.1136/jnnp.71.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Robertson N. P., Deans J., Compston D. A. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):492–496. doi: 10.1136/jnnp.65.4.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schon F., Drayson M., Thompson R. A. Myasthenia gravis and elderly people. Age Ageing. 1996 Jan;25(1):56–58. doi: 10.1093/ageing/25.1.56. [DOI] [PubMed] [Google Scholar]
  16. Slesak G., Melms A., Gerneth F., Sommer N., Weissert R., Dichgans J. Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60. Ann N Y Acad Sci. 1998 May 13;841:777–780. doi: 10.1111/j.1749-6632.1998.tb11017.x. [DOI] [PubMed] [Google Scholar]
  17. Somnier F. E. Myasthenia gravis. Dan Med Bull. 1996 Feb;43(1):1–10. [PubMed] [Google Scholar]
  18. Vincent A., Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry. 1985 Dec;48(12):1246–1252. doi: 10.1136/jnnp.48.12.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vincent A., Palace J., Hilton-Jones D. Myasthenia gravis. Lancet. 2001 Jun 30;357(9274):2122–2128. doi: 10.1016/S0140-6736(00)05186-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES